{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:40:21Z","timestamp":1790779221318,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacl.2026.04.033","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:48:42Z","timestamp":1777942122000},"page":"1367-1376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multidimensional lipid phenotyping for stratification of residual cardiovascular risk: A focus on fatty acid balance"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-8833","authenticated-orcid":false,"given":"Naoya","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3831-7241","authenticated-orcid":false,"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6948-0338","authenticated-orcid":false,"given":"Yuji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6792-8458","authenticated-orcid":false,"given":"Yuichiro","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.04.033_bib1","first-page":"516","article-title":"Complex PCI and 1-year outcomes in the OPTIVUS-complex PCI study multivessel cohort","volume":"40","author":"Gohbara","year":"2025","journal-title":"Cardiovasc\u00a0Interv\u00a0Ther"},{"key":"10.1016\/j.jacl.2026.04.033_bib2","first-page":"553","article-title":"Dual-prep registry: atherectomy devices and intravascular lithotripsy for the preparation of heavily calcified coronary lesions","volume":"40","author":"Nakamura","year":"2025","journal-title":"Cardiovasc\u00a0Interv\u00a0Ther"},{"key":"10.1016\/j.jacl.2026.04.033_bib3","first-page":"1550","article-title":"Early ezetimibe initiation after myocardial infarction protects against later cardiovascular outcomes in the SWEDEHEART registry","volume":"85","author":"Leosdottir","year":"2025","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.04.033_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117313","article-title":"Lipid-lowering in diabetes: an update","volume":"394","author":"Chait","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.04.033_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2513032","article-title":"Fish-oil supplementation and cardiovascular events in patients receiving hemodialysis","volume":"394","author":"Lok","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.04.033_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2011.04.040","article-title":"Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals","volume":"218","author":"Nakamura","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.04.033_bib7","first-page":"831","article-title":"Effect of omega-3 fatty acids on coronary plaque morphology: a serial computed tomography angiography study","volume":"86","author":"Motoyama","year":"2022","journal-title":"Circ\u00a0J"},{"key":"10.1016\/j.jacl.2026.04.033_bib8","first-page":"242","article-title":"Dietary exposure to polychlorinated biphenyls and risk of myocardial infarction: a population-based prospective cohort study","volume":"183","author":"Bergkvist","year":"2015","journal-title":"Int\u00a0J\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.04.033_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100997","article-title":"Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic review and meta-analysis","volume":"38","author":"Khan","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacl.2026.04.033_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2017.06.029","article-title":"Circulating malondialdehyde-modified low-density lipoprotein as a predictor of clinical outcome after endovascular therapy in peripheral artery disease","volume":"263","author":"Takamura","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.04.033_bib11","article-title":"Elevated lipoprotein(a) in patients with premature atherosclerotic cardiovascular disease: insights from a large US real-world cohort","author":"Hu","year":"2025","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.04.033_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120546","article-title":"Lp(a) in Argentina: a multicenter study on prevalence and clinical outcomes","volume":"411","author":"Corral","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.04.033_bib13","first-page":"1356","article-title":"Impact of lipoprotein(a) on long-term outcomes in patients with acute myocardial infarction","volume":"87","author":"Dai","year":"2023","journal-title":"Circ\u00a0J"},{"key":"10.1016\/j.jacl.2026.04.033_bib14","first-page":"2292","article-title":"Association of lipoprotein(a) with cardiovascular disease and all-cause mortality in U.S. Hispanics and Latinos","volume":"86","author":"Danilov","year":"2025","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.04.033_bib15","first-page":"272","article-title":"The modification of serum lipids after acute coronary syndrome and importance in clinical practice","volume":"7","author":"Balci","year":"2011","journal-title":"Curr\u00a0Cardiol\u00a0Rev"},{"key":"10.1016\/j.jacl.2026.04.033_bib16","first-page":"241","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med\u00a0Res\u00a0Methodol"},{"key":"10.1016\/j.jacl.2026.04.033_bib17","doi-asserted-by":"crossref","unstructured":"Shahapure KR, Nicholas C. Cluster quality analysis using Silhouette Score. In\u00a0Proceedings\u00a0IEEE 7th International Conference on Data Science and Advanced Analytics (DSAA), Sydney, Australia, 2020, pp. 747\u2013748.","DOI":"10.1109\/DSAA49011.2020.00096"},{"key":"10.1016\/j.jacl.2026.04.033_bib18","first-page":"138","article-title":"Rationale and design of REDUCE-IT: reduction of cardiovascular events with icosapent ethyl\u2013intervention trial","volume":"40","author":"Bhatt","year":"2017","journal-title":"Clin\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.04.033_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2026.04.033_bib20","first-page":"427","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.04.033_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/17460875.3.6.637","article-title":"Oxidized LDL and the metabolic syndrome","volume":"3","author":"Holvoet","year":"2008","journal-title":"Future Lipidol"},{"key":"10.1016\/j.jacl.2026.04.033_bib22","first-page":"2459","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: evidence from genetic, epidemiologic, and clinical studies","volume":"38","author":"Ference","year":"2017","journal-title":"Eur\u00a0Heart J"},{"key":"10.1016\/j.jacl.2026.04.033_bib23","first-page":"469","article-title":"Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance","volume":"1851","author":"Calder","year":"2015","journal-title":"Biochim\u00a0Biophys\u00a0Acta"},{"key":"10.1016\/j.jacl.2026.04.033_bib24","first-page":"2047","article-title":"Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.04.033_bib25","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Collaboration","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2026.04.033_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.118.034645","article-title":"Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy","volume":"138","author":"Pradhan","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.04.033_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl\u00a0J\u00a0Med"},{"key":"10.1016\/j.jacl.2026.04.033_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2026.04.033_bib29","first-page":"1540","article-title":"Effects of n-3 fatty acid supplements in diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"key":"10.1016\/j.jacl.2026.04.033_bib30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2026.04.033_bib31","first-page":"1685","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"key":"10.1016\/j.jacl.2026.04.033_bib32","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426001376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426001376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:30:29Z","timestamp":1786033829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426001376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1933287426001376"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.04.033","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidimensional lipid phenotyping for stratification of residual cardiovascular risk: A focus on fatty acid balance","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}